Immuno-epidemiology of human <it>Schistosoma haematobium </it>infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden

Immuno-epidemiology of human <it>Schistosoma haematobium </it>infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden

<p>Abstract</p> <p>Background</p> <p>Schistosomiasis is a major parasitic disease affecting over 200 million people in the developing world with a further 400 million people at risk of infection. The aim of this study was to identify a single antigen from adult <it&g...

Full description

Bibliographic Details
Main Authors:	Fernandez Cecilia, Gregory William F, Gomez-Escobar Natalia, Mduluza Takafira, Mutapi Francisca, Midzi Nicholas, Maizels Rick M
Format:	Article
Language:	English
Published:	BMC 2006-06-01
Series:	BMC Infectious Diseases
Online Access:	http://www.biomedcentral.com/1471-2334/6/96

Similar Items

Cytokine responses to <it>Schistosoma haematobium </it>in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age
by: Mduluza Takafira, et al.
Published: (2007-11-01)

The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium
by: Mutapi Francisca, et al.
Published: (2002-01-01)

Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
by: Kate M Mitchell, et al.
Published: (2014-01-01)

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011-05-01)

Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.
by: Laura J Appleby, et al.
Published: (2012-01-01)

Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children.
by: Gemma Louise Kay, et al.
Published: (2015-01-01)

CD16 expression on monocytes in healthy individuals but not schistosome-infected patients is positively associated with levels of parasite-specific IgG and IgG1.
by: Laura J Appleby, et al.
Published: (2014-08-01)

Diagnostic performances of Schistosoma haematobium and Schistosoma mansoni recombinant proteins, peptides and chimeric proteins antibody based tests. Systematic scoping review.
by: Arthur Vengesai, et al.
Published: (2023-01-01)

Diagnostic performances of Schistosoma haematobium and Schistosoma mansoni recombinant proteins, peptides and chimeric proteins antibody based tests. Systematic scoping review
by: Arthur Vengesai, et al.
Published: (2023-01-01)

Effect of Schistosoma haematobium infection on the cognitive functions of preschool age children and benefits of treatment from an endemic area in Zimbabwe
by: Maritha Kasambala, et al.
Published: (2022-10-01)

The association of systemic inflammation and cognitive functions of pre-school aged children residing in a Schistosoma haematobium endemic area in Zimbabwe
by: Maritha Kasambala, et al.
Published: (2023-04-01)

Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium
by: F Mutapi, et al.
Published: (2007-06-01)

Algorithm for diagnosis of early Schistosoma haematobium using prodromal signs and symptoms in pre-school age children in an endemic district in Zimbabwe.
by: Tariro L Mduluza-Jokonya, et al.
Published: (2021-08-01)

Effect of treating <it>Schistosoma haematobium </it>infection on <it>Plasmodium falciparum-specific </it>antibody responses
by: Mduluza T, et al.
Published: (2008-11-01)

In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.
by: Javier Sotillo, et al.
Published: (2019-05-01)

Plasma metabolite profiling for S. haematobium biomarkers of infection in pre-school aged children in Shamva District, Zimbabwe
by: Herald Midzi, et al.
Published: (2024-03-01)

Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers.
by: Gebeyaw G Mekonnen, et al.
Published: (2022-01-01)

Schistosoma haematobium
by: Cristina Corsini Campioli, et al.
Published: (2023-01-01)

Putting the treatment of paediatric schistosomiasis into context
by: Takafira Mduluza, et al.
Published: (2017-04-01)

Interleukin-10 and tumour necrosis factor alpha promoter region polymorphisms and susceptibility to urogenital schistosomiasis in young Zimbabwean children living in Schistosoma haematobium endemic regions
by: Amos Marume, et al.
Published: (2020-09-01)

Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment
by: Grace Zdesenko, et al.
Published: (2022-06-01)

Schistosoma haematobium–Schistosoma mansoni Hybrid Parasite in Migrant Boy, France, 2017
by: Yohann Le Govic, et al.
Published: (2019-02-01)

Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
by: Nada Abdel Aziz, et al.
Published: (2019-12-01)

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01)

Performance of a rapid immuno-chromatographic test (Schistosoma ICT IgG-IgM) for detecting Schistosoma-specific antibodies in sera of endemic and non-endemic populations.
by: Julie Hoermann, et al.
Published: (2022-05-01)

T cell clones from Schistosoma haematobium infected and exposed individuals lacking distinct cytokine profiles for Th1/Th2 polarisation
by: Mduluza T, et al.
Published: (2001-01-01)

Genetic profiles of Schistosoma haematobium parasites from Malian transmission hotspot areas
by: Privat Agniwo, et al.
Published: (2023-08-01)

Spatial distribution and ecology of soil parasites and Schistosoma haematobium infection in Eggua, Nigeria
by: Taiwo A Adekeye, et al.
Published: (2021-10-01)

Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment.
by: Norman Nausch, et al.
Published: (2015-03-01)

Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01)

CRISPR-assisted test for Schistosoma haematobium
by: Dounia Cherkaoui, et al.
Published: (2023-03-01)

Colon polyps in Schistosoma haematobium schistosomiasis
by: Celso Alberto Chassot, et al.
Published: (1998-01-01)

Schistosoma haematobium Infection and Buruli Ulcer
by: Janet T. Scott, et al.
Published: (2004-03-01)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
by: Angora Etienne K., et al.
Published: (2022-01-01)

Schistosome infection intensity is inversely related to auto-reactive antibody levels.
by: Francisca Mutapi, et al.
Published: (2011-05-01)

Multiplex peptide microarray profiling of antibody reactivity against neglected tropical diseases derived B-cell epitopes for serodiagnosis in Zimbabwe.
by: Arthur Vengesai, et al.
Published: (2022-01-01)

Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.
by: Welcome M Wami, et al.
Published: (2015-03-01)

Genetic manipulation of Schistosoma haematobium, the neglected schistosome.
by: Gabriel Rinaldi, et al.
Published: (2011-10-01)

The small RNA complement of adult Schistosoma haematobium.
by: Andreas J Stroehlein, et al.
Published: (2018-05-01)

Publisher Correction: Genetic profiles of Schistosoma haematobium parasites from Malian transmission hotspot areas
by: Privat Agniwo, et al.
Published: (2023-12-01)